Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Cantisani

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Proteome Research|January 2, 2010
Proteomic analysis of human U937 cell line activation mediated by Haemophilus influenzae type b P2 porin and its surface-exposed loop 7Valeria Severino, Angela Chambery, Mariateresa Vitiello, et al.
Journal of Medicinal Chemistry|October 29, 2013
Conformational modifications of gB from herpes simplex virus type 1 analyzed by synthetic peptidesMarco Cantisani, Annarita Falanga, Novella Incoronato, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 14, 2011
A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dotsAnnarita Falanga, Maria Teresa Vitiello, Marco Cantisani, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2014
Structural insights into and activity analysis of the antimicrobial peptide myxinidinMarco Cantisani, Emiliana Finamore, Eleonora Mignogna, et al.
International Journal of Nanomedicine|October 29, 2015
Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial toolOlga Scudiero, Ersilia Nigro, Marco Cantisani, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activityOlga Scudiero, Stefania Galdiero, Marco Cantisani, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell linesOlga Scudiero, Stefania Galdiero, Ersilia Nigro, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Proteome Research|January 2, 2010
Proteomic analysis of human U937 cell line activation mediated by Haemophilus influenzae type b P2 porin and its surface-exposed loop 7Valeria Severino, Angela Chambery, Mariateresa Vitiello, et al.
Journal of Medicinal Chemistry|October 29, 2013
Conformational modifications of gB from herpes simplex virus type 1 analyzed by synthetic peptidesMarco Cantisani, Annarita Falanga, Novella Incoronato, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 14, 2011
A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dotsAnnarita Falanga, Maria Teresa Vitiello, Marco Cantisani, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2014
Structural insights into and activity analysis of the antimicrobial peptide myxinidinMarco Cantisani, Emiliana Finamore, Eleonora Mignogna, et al.
International Journal of Nanomedicine|October 29, 2015
Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial toolOlga Scudiero, Ersilia Nigro, Marco Cantisani, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activityOlga Scudiero, Stefania Galdiero, Marco Cantisani, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell linesOlga Scudiero, Stefania Galdiero, Ersilia Nigro, et al.
Pageof 3